SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant volatility as investors react to the finalized Medicare Advantage rate increase for 2027, which arrived notably higher than initial market projections. While many in the community view this as a potential relief catalyst and a sign of sector stabilization, others remain cautious, debating the long-term impact of regulatory pressures and ongoing volatility across the managed care space.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently a focal point for the investment community as the company expands its strategic partnerships, specifically securing long-term agreements to supply custom artificial intelligence chips and infrastructure to industry giants like Google and Anthropic. While some investors are concerned about potential supply chain bottlenecks and short-term price volatility, others are debating the stock's fundamental valuation and viewing the recent dips as an opportunity to gain exposure to critical AI infrastructure.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant selling pressure after a major financial institution reiterated a bearish outlook, citing concerns over future growth, execution risks, and a valuation that many investors now see as disconnected from weakening fundamentals. Community sentiment is deeply polarized, with bears pointing to inventory headwinds and the upcoming SpaceX IPO as potential catalysts for further downside, while a vocal group of bulls remains optimistic, viewing the pullback as a buying opportunity based on their long-term conviction in the company's AI and robotics initiatives.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is seeing elevated bullish options activity and heightened community discourse as traders debate whether the stock is currently undergoing a technical accumulation phase or if ongoing manufacturing scaling challenges will continue to suppress price momentum. While speculative reports of a partnership with Meta-Bounds have fueled sentiment, investors remain focused on the company's ability to transition from pilot programs to high-volume commercial production.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is seeing significant volatility as investors digest finalized 2027 Medicare Advantage payment rates, which came in stronger than the initial government projections. The community is actively debating whether this relief rally provides a sustainable floor for the stock or if broader structural headwinds and regulatory pressures in the managed care sector will continue to weigh on long-term growth.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is attracting significant attention as investors speculate on potential buyout scenarios and aggressive international expansion, while heavy short interest continues to fuel intense debate regarding a possible short squeeze. The community is actively tracking the stock's relative strength and attractive dividend yield, often framing the current price levels as a prime accumulation opportunity ahead of anticipated leadership or acquisition news.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing intense volatility and downward pressure as the market reacts to a significant debt-related financing announcement and concerns over persistent high interest expenses. While the community is actively debating the stock's long-term sustainability due to its heavy debt load and potential for dilution, many traders are closely watching for a short squeeze setup, noting the stock's high institutional ownership and historical tendency for sudden, aggressive price swings.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is generating significant momentum as a legacy meme asset, with community members actively discussing its long-term cultural roots and potential as a disruptive force in the cryptocurrency space. Sentiment is divided between those treating it as a lighthearted, narrative-driven project and believers who argue its deep historical footprint distinguishes it from modern market cycles.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing renewed investor interest driven by a successful $600 million AAA-rated ABS transaction and the addition of new institutional partners, reinforcing confidence in its AI-driven credit underwriting model. The community is actively discussing the stock's oversold technical setup and its potential for a recovery as the company continues to onboard new partners despite broader macro-economic and geopolitical headwinds.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as market sentiment shifts following a relief rally for managed care stocks, driven by finalized CMS payment rates for Medicare Advantage that were more favorable than investors initially feared. The community is actively discussing the impact on earnings risk and the potential for a sector-wide re-rating, alongside ongoing debate regarding the company's long-term integration strategy and PBM business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics (NASDAQ:WHWK) CEO Sells $93,465.84 in Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CEO David James Lennon sold 26,858 shares of the company's stock in a transaction that occurred on Thursday, April 2nd. The shares were...

Whitehawk Therapeutics (NASDAQ:WHWK) CEO David James Lennon Sells 26,858 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CEO David James Lennon sold 26,858 shares of the business's stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $3.48, for a total transaction of $93,465.84. Following the sale, the chief executive...

Wall Street Zen Upgrades Whitehawk Therapeutics (NASDAQ:WHWK) to Hold

Wall Street Zen raised Whitehawk Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 Whitehawk Therapeutics to Highlight its...

Ally Bridge Group NY LLC Takes $1.55 Million Position in Whitehawk Therapeutics, Inc. $WHWK

Ally Bridge Group NY LLC acquired a new stake in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities...

2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC acquired a new position in shares of Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Free Report) in the 3rd quarter, according to its most recent 13F filing with the...

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent...

Insider Selling: Whitehawk Therapeutics (NASDAQ:WHWK) CEO Sells 5,100 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CEO David James Lennon sold 5,100 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price...

David James Lennon Sells 5,100 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CEO David James Lennon sold 5,100 shares of Whitehawk Therapeutics stock in a transaction that occurred on Monday, March 2nd. The shares...

Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027

Whitehawk Therapeutics CEO Dave Lennon outlined the company's strategy and near-term milestones at the Inaugural Life Sciences Conference in Miami, describing a three-program antibody-drug conjugate...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

Current Price	$3.50
Prev Close	$3.51
Open	$3.50
Dividend Yield	0.00%
50-Day Moving Average	$3.26
Beta	1.09
Avg. Volume	210,615.74
PE Ratio	7.40

52-Week High	$4.48
52-Week Low	$1.39
Market Capitalization	$165.66M
EPS (Annual)	-$0.3328
Price to Book	1.21
Revenue Per Employee	$310,652.17

WHWK
Whitehawk Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WHWK News

WHWKWhitehawk Therapeutics Inc.